Get started
Author

Adeline Lesnier

Observed name: Lesnier, Adeline
ORCID: 0009-0006-2886-6924
Observed ORCID: 0009-0006-2886-6924
OpenAlex ID: A5062316107
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers
2023 · Anja Seckinger, Sara Majocchi, et al. · Journal of Hematology & Oncology · 24
PDF
Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies
2025 · Julien Montorfani, Eric Hatterer, et al. · Journal for ImmunoTherapy of Cancer · 3
PDF
Abstract 2951: NI-2901, an affinity-optimized CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade
2023 · Xavier Chauchet, Sebastien Calloud, et al. · Cancer Research · 1
Abstract 5532: Bispecific antibodies targeting EGFR and HER2 for effective killing of solid tumor cells via a safe CD47-SIRPA modulation
2026 · Eric Hatterer, Vanessa Buatois, et al. · Cancer Research
Abstract 5293: Preclinical development of NI-3201, a PD-L1xCD28 bispecific antibody mediating CD28 costimulation upon PD-L1 blockade
2024 · Sara Majocchi, Nadia Anceriz, et al. · Cancer Research
481 An affinity-optimized CD47xPD-L1 bispecific antibody for dual immune checkpoint blockade
2022 · Xavier Chauchet, Sebastien Calloud, et al. · Journal for ImmunoTherapy of Cancer
PDF
Works count: 8
Citation count: 28
H-index: 2
I10-index: 1
Year
Topic
Type